Category - Pharma Industry
Can a regulatory revamp restore the shine of the ‘pharmacy of the world’ sullied by flaws?
After Vijaya Diagnostic’s tepid IPO, can strong financials and regional presence lift it up?
Aurobindo Pharma: A muddled deal has scarred Aurobindo Pharma. Regaining investor confidence won’t be easy.
The Kumbh testing scam is a symptom of chronic disease in pathology labs. What are ICMR, NABL doing?
Zero quality tests, incorrect readings yet China-made pulse oximeters are flooding the Indian market
China is out to strangle India’s bulk drug makers. The government needs to heed the industry’s SOS.
Krsnaa Diagnostics’ IPO garnered investor interest. Can it become the next Dr PathLabs, Thyrocare?
Genome meets GitHub: Using tech tools, India’s virus hunters track a shape-shifting killer
